We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PHX market cap is 47.88M. The company's latest EPS is AUD -0.0030 and P/E is -26.67.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 10.55M | 13.27M | 12.79M | 11.92M | 9.06M |
| Operating Income | -1.37M | -340k | 270k | -339k | -1.41M |
| Net Income | 176k | 1.09M | 252k | -1.05M | -1.77M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 19.18M | 31.35M | 30.77M | 36.52M | 29.86M |
| Total Liabilities | 5.98M | 8.42M | 7.57M | 14.31M | 13.89M |
| Total Equity | 13.2M | 22.93M | 23.2M | 22.21M | 15.97M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 369k | 3.16M | 3.28M | 10.94M | 3.21M |
| Investing | -3.34M | -6.19M | -3.64M | -3.57M | 1.75M |
| Financing | 2.96M | 7.18M | -361k | -325k | -4.62M |
| Market Cap | 47.88M |
| Price to Earnings Ratio | -26.67 |
| Price to Sales Ratio | 5.3 |
| Price to Cash Ratio | 3.65 |
| Price to Book Ratio | 3 |
| Dividend Yield | - |
| Shares Outstanding | 598.51M |
| Average Volume (1 week) | 646.1k |
| Average Volume (1 Month) | 414.38k |
| 52 Week Change | 122.22% |
| 52 Week High | 0.085 |
| 52 Week Low | 0.012 |
| Spread (Intraday) | 0 (1.25%) |
| Company Name | PharmX Technologies Limited |
| Address |
level 3 sydney, new south wales 2000 |
| Website | https://www.pharmx.com.au |
| Industry | prepackaged software (7372) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
